AzTrials
AzTrials

Aortic AneurysmNCT07422129

Multidisciplinary Analysis by Morphological and Mechanical Evaluation of the Aortic Wall in Patients Undergoing Cardiac Surgery.

An observational study of Aortic Aneurysm and Aortic Aneurysm and Dissection, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Surgical indication in patients suffering from Ascending aorta aneurysm is currently based mainly on the maximum diameter of the aortic dilatation and on the yearly growth rate. Several clinical preoperative patients characteristics have been, potentially, correlated to impaired mechanical characteristics of aortic… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
250 participants
Where
1 siteItaly
Study dates
24 Mar 2015to 31 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The primary study population consisted of patients referred for ascending aortic/aortic root dilation surgery. The study evolved to include control groups including patients with acute aortic dissection and patients without aortic disease undergoing heart transplantation.

Who may be able to join

  • Patients undergoing surgery including ascending aorta replacement at our Department and/or heart transplantation

Who cannot join

  • Patients with biological hazard (HBC/HIV +)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pasquale Totaro, MD contact

3283678762

p.totaro@matteo.pv.it

Italy1 site, 1 recruiting
  • Fondazione IRCCS Policlinico San Matteo di Pavia

    Pavia, Lombardy, 27100

    Pasquale Totaro, MD, 3283678762, p.totaro@matteo.pv.it

    Recruiting

Other trials in Italy

About this study

Official title: Multidisciplinary Analysis by Morphological and Mechanical Evaluation of the Aortic Wall in Patients With Aortic Disease, Undergoing Aortic Cardiac Surgery, vs Patients Without Aortic Disease

Surgical indication in patients suffering from Ascending aorta aneurysm is currently based mainly on the maximum diameter of the aortic dilatation and on the yearly growth rate. Several clinical preoperative patients characteristics have been, potentially, correlated to impaired mechanical characteristics of aortic wall, and therefore to an increased risk of rupture and or dissection. On other hands, such suppositions have been never confirmed, as a full characterization of the mechanical behaviour of the ascending aortic tissue, especially in case of aneurysm, has not been fully clarified yet. Objective of this observational study is to better elucidate, using direct in vivo evaluation, the mechanical characteristics of the aortic wall in patients with ascending aorta diseases. Our study will have a further peculiar characteristic as we have the intention of compare such mechanical characteristics to those of patients, without known aortic diseases, undergoing heart transplantation. Potential correlation between, directly measured mechanical characteristics of the aortic wall, and preoperative parameters (anagraphic patients characteristics, clinical data and diagnostic tests) will be also investigated.

Read the detailed description
  1. Patients selection All patients undergoing cardiac surgery procedures requiring ascending aorta replacement could be enrolled in the study, providing that they will sign the specific informed consent. In these patients (Group A), at surgery, following routine collection of specimens for standard histological and/or biochemical evaluation, all residual specimens are collected, stored, and sent for anonymous mechanical tests at the Department of Civil Engineering of the University of Pavia for the full protocol of the tests). There will be no specific contraindication to patient inclusion in the study except in case of high biological hazard (i.e. HCV+ patients). Patient inclusion in the study and specimen collection, therefore, will not interfere in any way with the diagnostic and therapeutic decision-making process. As a control group, we will also enroll, pending specific consensus, patients undergoing heart transplantation. In this group of patients (Group B), once the cardiotomy is completed, selected specimens of the removed ascending aorta will be stored and sent to the Department of Engineering of the University of Pavia using the same protocol. Group B could also include specimens from donor's hearts, harvested at the time of transplantation.
  2. Specimen's Collection and preparation Once the selected portion of the ascending aorta is removed, according to the surgical procedure, specimens for routine investigations are collected and prepared for histological evaluation as per the current protocol. The residual portion is divided into specimens, which will be identified according to the orientation and the anatomical position as A1, A2, and A3 (anterior portion respectively from the ST junction to the tubular portion and finally to the distal portion close to the innominate artery) and P1, P2 (posterior portion respectively from the proximal portion to the distal portion). Once all specimens are identified, they will be stored in isotonic physiological solution and kept in a refrigerator at 4°C until mechanical testing will be performed. They will be all collected in one single box identified with a numerical progressive code (i.e. P1, P2, etc) without any further information regarding the patient's characteristics. Patient data and their correlation to the progressive code will be only available in the specific database, which will be under the direct responsibility of the principal investigator of the study .
  3. Mechanical Properties Analysis Mechanical uniaxial tensile ultimate stress test are performed on the fresh "ex vivo" sample within 24 hours from the harvesting. Briefly, from the full cylinder, a number of samples with a dog-bone shape and a length/width ratio of at least 4:1 are prepared. Samples are divided and identified according the region of the aortic wall (anterior/greater curvature and posterior/lesser curvature). The number of samples obtained from each patient are related to the original dimension of the harvested aortic cylinder and usually ranged from 2 to 13. The dog-bone shape allowed a central narrow region, identified by two black markers. Before mechanical tests, the thickness of each samples of aortic wall (awTK) is accurately measured with a dedicated calibre. Tests are, then, performed using a MTS insight testing system 10 kN (MTS system corporation) using uniaxial circumferential and/or longitudinal force. Each test is identified according the region of the aorta where the specimen was harvested and the direction of the applied force. Three ultimate mechanical properties parameters will be measured : Peak Strain (Pstr) as the maximum strain before specimen rupture (marker of aortic wall elasticity); Peak Stress (PS) as the maximum stress before specimen rupture (marker of aortic wall strength) and Maximum Elastic Modulus (EM) as the maximum slope of stress/strain curve (marker of aortic wall stiffness or resistance to deformation).
  4. Statistical analysis Based on a previous series of test and on the standard deviation obtained for the three main mechanic parameters measured: Peek Strain, Peek stress and Elastic modulus (0.11 mm, 0.756 MPa and 17.88 MPa respectively) we calculated a sample size of 22 patients each groups to detect a difference equal to 1sd with a power of (90% error and 0.5% error ). Furthermore, based on the number of patients undergoing ascending aortic surgery at our Division in the last three years (nearly 100py), and on the patients characteristics (age, gender, presence of bicuspid aortic valve), we aim to collect at least 60-80 patients in one year, and to identify, with significant statistical power, potential mechanical characteristics differences related to gender, age >70 years and the presence of native bicuspid valve.

Summary of description of statistical analysis:

Statistical analysis will be performed using MedCalc Statistical Software. Continuous variables will be tested for normality of distribution using a Kolmogorov-Smirnov tests. According to the result of the normal distribution, continuous variables will be then summarized as mean plus/minus SD or median [IQR]. Differences between two groups (i.e. female/male, below/above 70 yo, bicuspid/tricuspid native aortic valve) will be compared trough the unpaired t-test and analysis of variance (with Bonferroni test) or Mann-Whitney U-test and Kruskal-Wallis in case of parametric or non parametric distribu tion respectively (p<0.05 was considered statistically significant). The statistic relations between different continuous variables (i.e mechanical tests and age, extension of aortic dilatation, extension of indexed aortic dilatation, preoperative TTE calculated aortic elasticity etc etc, will be evaluated by mean of a linear regression analysis, using the Pearson's correlation coefficent (r) and assuming as significant a p value <0.005. Finally a multivariate regression models (forward stepwise) will be carried out to identify the predictors of a severely impaired mechanical properties (i.e. Peek Strain and Peek Stress <25th percentile and Elastic Modulus >75th percentile).

Medical subject headings
Aortic Aneurysm, Aortic Dissection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07422129
Study groupRoleWhat they receive
2 main groups: Diseased Aorta and non-diseased aortaDiseased aorta included patients with chronic aortic aneurysm and patients with aortic dissection. Control group included non diseased aorta undergoing surgery for heart transplantation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identification of extreme aortic wall fragility in relation to demographic or pathological characteristics of the enrolled patients.

    The execution of the above tests, and the following analysis and post-processing of the tests response will allow the characterization of ultimate mechanical properties using three main parameters:

    1. Peak Strein (the maximum strein before specimen rupture)
    2. Peak Stress (the maximum stress before specimen rupture)
    3. Maximum Elastic Modulus (the maximum slope of the stress-strain curve The identification of extreme aortic wall fragility will be based primarily on extreme values of the first two parameters (<25th percentile). For the third parameter, both extreme values (<25th and >75th percentile) will be considered.

    As a further parameter of fragility, an abnormal increase in intra-patient variability will also be considered, in case of the possibility of multiple tests.

    Measured: Perioperative (Within 24 hours from surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2026
  2. Study start24 Mar 2015
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07422129
Sponsor's protocol ID
APA
Status last verified
Feb 2026
First submitted
3 Feb 2026
Last updated
19 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aortic Aneurysm and Aortic Aneurysm and Dissection, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pasquale Totaro, MD (3283678762, p.totaro@matteo.pv.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identification of extreme aortic wall fragility in relation to demographic or pathological characteristics of the enrolled patients. (time frame: Perioperative (Within 24 hours from surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in